LOXL2 and hepatocellular carcinoma: More notably, Wong et al. demonstrated that miR-29a acts as a negative regulator on lysyl oxidase like 2 (LOXL2) through interacting with the 3’UTR, thereby impeding the HCC metastasis [64].